Trump Threatens Big Pharma With Tariffs—Unless They Reshore Manufacturing: Bloomberg - BioSpace
President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.| BioSpace
President Trump also refused to promise pharma execs that he would hamstring the IRA’s drug negotiation program.| BioSpace
The move comes after President Donald Trump warned Big Pharma leaders that he would impose tariffs on them if they refuse to reshore their manufacturing operations.| BioSpace
Johnson & Johnson follows Eli Lilly in spending billions on U.S. manufacturing after President Donald Trump threatened major tariffs on pharmaceutical products. Pfizer has also promised a similar commitment.| BioSpace
2024 was a tough year for the biopharma industry, with several companies cutting hundreds or even thousands of employees. Follow along as BioSpace tracks job cuts and restructuring initiatives throughout 2025.| BioSpace
